[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.176.35. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Medical News and Perspectives
February 18, 2004

New Anti-BSE Rules Imposed

JAMA. 2004;291(7):810. doi:10.1001/jama.291.7.810

The Food and Drug Administration (FDA) continues to implement more stringent regulations to thwart the potential spread of bovine spongiform encephalopathy (BSE, or "mad cow" disease) in the United States after the discovery of an infected Holstein in December. The agency has now imposed several bans that will affect human food, including dietary supplements, and cosmetics.

Material from "downer" cattle (animals too sick or injured to stand) or cattle that die before slaughter will be banned, along with other bovine-derived material, including risk materials from any cows 30 months or older (such as brain, skull, eyes, and spinal cord), as well as a portion of the small intestine and tonsils from all cattle.

First Page Preview View Large
First page PDF preview
First page PDF preview
×